BusinessWorld Online takes the position that Ozempic shouldn't be thought of as a weight loss drug. Only the headline is available, so tap through for the argument.
Recap by typeshit. Full story at BusinessWorld Online.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
Months after an advisory panel backed easing limits on BPC-157 and others, Medical Daily reviews hospitalizations and Nevada fines over two intubated women.
Nurturher Aesthetics explains why most providers aren't using retatrutide, pointing out that the Lilly drug has no FDA approval yet.
Loading…